SCHEMBL19785401

SCHEMBL19785401

CC(C)(C)OC(=O)n1c2ccc(C(F)(F)F)cc2c2cc(C(F)(F)F)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 2/20 0.52
GABRB3 P28472 2/20 0.52
GABRA5 P31644 2/20 0.52
MAP2K4 P45985 1/20 0.50
GABRA1 P14867 1/20 0.49
GABRA2 P47869 1/20 0.49
GABRA6 Q16445 1/20 0.49
MAPT P10636 1/20 0.48
CACNA1B Q00975 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
NR1H2 P55055 1/20 0.40
SRC P12931 1/20 0.40
GPR119 Q8TDV5 2/20 0.39
RAPGEF3 O95398 1/20 0.39
RAPGEF4 Q8WZA2 1/20 0.39
KIF11 P52732 1/20 0.39
PPARG P37231 3/20 0.39
TGFBR1 P36897 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24125933 0.86 GABRG2 (0.53) GABRG2GABRB3GABRA5MAP2K4GABRA1
SCHEMBL16729380 0.83 AKR1C3 (0.45) GABRG2GABRB3GABRA5MAP2K4GABRA1
SCHEMBL16729563 0.83 MAP2K4 (0.43) GABRG2GABRB3GABRA5MAP2K4GABRA1
SCHEMBL16729385 0.82 AKR1C3 (0.44) GABRG2GABRB3GABRA5MAP2K4GABRA1
SCHEMBL20858533 0.78 GABRG2 (0.48) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL10064601 0.78 GABRG2 (0.72) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL409607 0.78 CDK1 (0.54) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL1144957 0.78 GABRG2 (0.51) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL15708456 0.78 MAP2K4 (0.61) GABRG2GABRB3GABRA5MAP2K4GABRA1
SCHEMBL31370537 0.78 MAP2K4 (0.47) GABRG2GABRB3GABRA5MAP2K4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10246415-B2 Process for preparing carbazoles DOW GLOBAL TECHNOLOGIES LLC (US) 2019-04-02 US disclosed
WO-2018013067-A1 PROCESS FOR PREPARING CARBAZOLES DOW GLOBAL TECHNOLOGIES LLC (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10246415-B2 Process for preparing carbazoles DCLK2, DCLK1, PDCD2L GABRG2 951/4885GABRB3 328/4885GABRA5 428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.